Shift work is a predictor of chronic disease risk. However, to date, the critical dose of exposure to shift work required to impact health remains unclear. We seek to develop improved exposure metrics to better capture the occupational strain linked to work schedules, and, in particular, shift work. One factor thought to underlie the association between shift work and adverse health outcomes is the interference of work times with the individual 24h-rhythm in physiology and behavior: because activity, food intake and light exposure take place at inappropriate biological times (i.e. during the individual biological night) work schedules induce a certain level of circadian strain (or disruption). Yet 24h-rhythms exhibit large inter-individual variability as far as timing of sleep and wake behavior are concerned; this variability is also referred to as chronotype. For example, early chronotypes - if free of social and work constraints - tend to fall asleep and wake up significantly earlier in the 24h day than late chronotypes. It appears therefore plausible that occupational circadian strain depends not only on the work schedule itself, but also on an individual's respective chronotype.
We aim to address this question by developing novel exposure metrics that rely on the conjunct assessment of chronotype and work schedules and linking them to BMI - a prime mediator of chronic disease risk. In the Nurses' Health Study 3 (NHS3), we implemented highly detailed work schedule assessments. In addition, we also introduced the two prime measures of chronotype. Based on these measures, we will develop two circadian strain metrics that, ultimately, could be applied and generalized to a wide range of studies. We will conduct a systematic comparison of the two chronotype measures and the newly developed circadian strain metrics across work schedules. Next, we will apply these metrics to the Nurses' Health Study 2 and NHS3 to examine associations between occupational circadian strain and body mass index, a central chronic disease mediator that has previously been associated with circadian strain in animal and experimental studies. In sum, we seek to develop widely applicable metrics for personalized occupational risk assessment, reflecting personalized circadian strain as one of the central biological mechanisms linking shift work and adverse health outcomes. Ultimately, these newly developed metrics can be used to examine the relationship between work schedule-associated circadian strain and health and safety outcomes, and identify critical doses for prevention strategies, across industry settings and sectors.

Public Health Relevance

Shift work is a risk factor for a range of chronic diseases, but to date, we have not been successful to determine a critical dose of exposure. We seek to improve current shift work assessments by developing novel circadian exposure metrics that combine detailed work schedule information with chronotype assessments reflecting an individual's 24h rhythm. Chronotype has previously been shown to modulate sleep and health outcomes in shift workers. If successful, this project will improve occupational risk assessment and provide tools to measure occupational strain in observational and intervention studies, as well as provide guidance for the design of healthier work schedules.

Agency
National Institute of Health (NIH)
Institute
National Institute for Occupational Safety and Health (NIOSH)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21OH011052-02
Application #
9437581
Study Section
Safety and Occupational Health Study Section (SOH)
Program Officer
Karr, Joan
Project Start
2016-09-01
Project End
2018-08-31
Budget Start
2017-09-01
Budget End
2018-08-31
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Vetter, CĂ©line; Chang, Shun-Chiao; Devore, Elizabeth E et al. (2018) Prospective study of chronotype and incident depression among middle- and older-aged women in the Nurses' Health Study II. J Psychiatr Res 103:156-160